VAXART (VXRT): vaccino Coronavirus - Pagina 5
Grecia, New York o Maldive: quanto accantonare ogni mese per la vacanza dei sogni e quanto si risparmia investendo tali somme
Tento di vacanze per milioni di italiani chiamati a scontrarsi con il problema budget. Le ferie estive, qualunque sia la meta, rappresentano probabilmente la spesa extra più importante ogni anno. …
Piazza Affari archivia luglio con una giornata no, balzo PIL non basta. Debacle di Enel e Saipem dopo i conti
Finale di ottava sottotono per Piazza Affari in una giornata cadenzata dal newsflow legato ai conti trimestrali e al riaccendersi della miccia M&A tra le banche con l’avvio dei colloqui …
L’Italia di Draghi corre il doppio del previsto, PIL fa nettamente meglio di Germania e Francia. Rischio frenata in mesi autunnali con variante delta
Sorpresa positiva dal Pil dell'Italia che nel secondo trimestre ha accelerato più del previsto, dando un segnale incoraggiante riguardo la ripresa economica in atto dopo un inizio 2021 in lieve …
Tutti gli articoli
Tutti gli articoli Tutte le notizie

  1. #41
    L'avatar di coffeman
    Data Registrazione
    Jun 2004
    Messaggi
    26,468
    Mentioned
    11 Post(s)
    Quoted
    6670 Post(s)
    Potenza rep
    42949690
    sempre più bravi.
    Anteprime Allegate Anteprime Allegate VAXART (VXRT): vaccino Coronavirus-immagine-2021-04-27-210614.png  

  2. #42
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693
    anche oggi, tonica e ben scambiata in apertura

  3. #43
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693
    bella candela oggi, lunedì potrebbe essere la giornata della speculazione, vedremo

  4. #44
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693
    Lunedì si balla, bisognerà saper cogliere l'attimo

    Why Vaxart Stock Is Soaring Today
    The biotech is slated to provide updates to investors on its vaccine development efforts next week.

    Joe Tenebruso
    (TMFGuardian)
    Apr 30, 2021 at 6:17PM

    Shares of Vaxart (NASDAQ:VXRT) surged 17% Friday, furthering a sharp rally in the biotechnology company's stock price in recent days.

    So what
    Vaxart released a study on April 22 indicating that almost 19 million more American adults would get COVID-19 vaccines if they could do so via a pill rather than a shot. "Needle injections present a barrier to getting people vaccinated, and we have a solution that we believe will be effective and would allow people to avoid injections they don't want to have," Vaxart CEO Andrei Floroiu said in a press release.

    A phase 1 study showed Vaxart's oral tablet COVID-19 vaccine candidate induced T-cell responses in patients, which the company believes could protect against new coronavirus strains. Vaxart's vaccine was also found to be generally well tolerated.

    Now what
    Investors appear to be eagerly awaiting upcoming presentations by Vaxart's management team. On Monday, the company will host a webinar on the importance of T-cell responses for COVID-19 and share new comparative data for its vaccine candidate. Vaxart founder and chief scientific officer Sean Tucker will also give a presentation next week at the World Vaccine Congress Washington regarding the benefits of its oral vaccine.

    Additionally, Vaxart has become increasingly popular among traders on Reddit and other social media platforms in recent weeks. This is no doubt amplifying the moves in its stock price, which is likely to remain volatile.

    VAXART (VXRT): vaccino Coronavirus-vxrt.jpg

  5. #45
    L'avatar di Dr Strangelove
    Data Registrazione
    Aug 2017
    Messaggi
    156
    Mentioned
    0 Post(s)
    Quoted
    43 Post(s)
    Potenza rep
    5238072
    Citazione Originariamente Scritto da BigNick Visualizza Messaggio
    Lunedì si balla, bisognerà saper cogliere l'attimo
    .

  6. #46
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693
    Citazione Originariamente Scritto da Dr Strangelove Visualizza Messaggio
    .
    Se son rose fioriranno
    vanno colte al momento giusto, prima che appassiscano...

    Questa è la situazione dello short volume ratio:

  7. #47
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693
    VAXART (VXRT): vaccino Coronavirus-vxrt.jpg

  8. #48
    L'avatar di Nean
    Data Registrazione
    Oct 2017
    Messaggi
    278
    Mentioned
    0 Post(s)
    Quoted
    82 Post(s)
    Potenza rep
    5714380
    titolo interessante
    vaccino per uso orale, la speculazione potrebbe farlo muovere bene

  9. #49
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693
    Citazione Originariamente Scritto da Nean Visualizza Messaggio
    titolo interessante
    vaccino per uso orale, la speculazione potrebbe farlo muovere bene
    esatto...

    Why Vaxart Stock Is Soaring Today | The Motley Fool
    "Vaxart released a study on April 22 indicating that almost 19 million more American adults would get COVID-19 vaccines if they could do so via a pill rather than a shot. "Needle injections present a barrier to getting people vaccinated, and we have a solution that we believe will be effective and would allow people to avoid injections they don't want to have," Vaxart CEO Andrei Floroiu said in a press release.

    A phase 1 study showed Vaxart's oral tablet COVID-19 vaccine candidate induced T-cell responses in patients, which the company believes could protect against new coronavirus strains. Vaxart's vaccine was also found to be generally well tolerated.

    Now what
    Investors appear to be eagerly awaiting upcoming presentations by Vaxart's management team. On Monday, the company will host a webinar on the importance of T-cell responses for COVID-19 and share new comparative data for its vaccine candidate. Vaxart founder and chief scientific officer Sean Tucker will also give a presentation next week at the World Vaccine Congress Washington regarding the benefits of its oral vaccine.

    Additionally, Vaxart has become increasingly popular among traders on Reddit and other social media platforms in recent weeks. This is no doubt amplifying the moves in its stock price, which is likely to remain volatile."


    Ricordo che domani ci sarà un webinar alle 12:00 p.m.
    Vaxart to Host a Key Opinion Leader Webinar on the Importance of T-Cell Responses for COVID-19 Vaccines
    Vaxart to provide new data from its Phase I COVID-19 trial

    Stanford University T-cell expert to discuss cross-protection against variants

    SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it will host a webinar on the importance of T-cell responses for COVID-19 vaccines on Monday, May 3, 2021 at 12:00 p.m. Eastern Time.


    inolte dal 4 al 6 maggio parteciperà al World Vaccine Congress Washington:
    Vaxart to Present at the World Vaccine Congress Washington 2021
    SOUTH SAN FRANCISCO, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the upcoming World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.

    Dr. Tucker’s presentation titled, “Vaxart oral COVID-19 vaccine; hold the ice and the needles,” will provide insight into the Company’s response and approach to addressing the COVID-19 pandemic with a room temperature oral tablet vaccine that is potentially protective against new and emerging COVID-19 strains.

    Presentation details are as follows:
    Title: Vaxart oral COVID-19 vaccine; hold the ice and the needles
    Track: COVID-19: vaccine response & approaches
    Time: 5:00 p.m. ET

    insomma di carne al fuoco ne abbiamo parecchia

  10. #50
    L'avatar di BigNick
    Data Registrazione
    Jul 2001
    Messaggi
    11,125
    Mentioned
    9 Post(s)
    Quoted
    1588 Post(s)
    Potenza rep
    42949693

Accedi